The New England Journal of Medicine recently published the results of the SELECT Study, giving valuable insights into the complex disease of obesity. The study shows Semaglutide can help prevent heart problems like cardiovascular deaths, strokes and heart attacks in people with obesity. In response, the country’s leading obesity expert organizations, the Obesity Action Coalition (OAC),
Read Article